(XLV) Health Care Sector Fund - Overview
ETF Category: Health | Exchange: NYSE ARCA (USA) | Market Cap: 39.083m USD | Total Return: 14.6% in 12m
TER: 0.09%
Avg Turnover: 2.19B USD
Peers RS (IBD): 34.6
Warnings
No concerns identified
Tailwinds
No distinct edge detected
XLV is an exchange-traded fund (ETF) tracking a healthcare sector index. It primarily invests in the securities of that index, holding at least 95% of its assets in those components.
The funds holdings span diverse healthcare industries. These include pharmaceuticals, a sector focused on drug discovery and manufacturing, and biotechnology, which utilizes biological processes for product development. Other industries within the fund are healthcare equipment and supplies, healthcare providers and services, life sciences tools and services, and health care technology.
XLV is classified as non-diversified. Further research on ValueRay can provide more in-depth analysis of its holdings and performance.
- Pharmaceutical patent expirations impact drug manufacturer revenue
- Healthcare policy changes create regulatory uncertainty
- Medical device innovation drives sector growth
- Biotechnology breakthroughs boost investment sentiment
- Healthcare service demand increases with aging population
Over the past week, the price has changed by +1.31%, over one month by -2.58%, over three months by -4.95% and over the past year by +14.56%.
| Analysts Target Price | - | - |